Megasoft

MEGASOFT26 Apr 2024

Pharmaceuticals

₹

+1.03 (+1.35%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Megasoft

Megasoft

Pharmaceuticals

MEGASOFT26 Apr 2024

₹

+1.03 (+1.35%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
22-Feb-2008	D	Megasoft Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 22, 2008, inter alia, has recommended a dividend of 12% on equity shares of Rs 10 each subject to the approval of the shareholders of the Company.	10-Jun-2008
29-Mar-2007	D	Megasoft Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 29, 2007, inter alia, has recommended a dividend of Rupee One per share (10%) subject to the approval of the shareholders of the Company.	18-Jun-2007
07-Jul-2021	R	2:3 Rights Issue of Equity Shares Trading Members of the Exchange are hereby informed that, Megasoft Limited. has fixed the Record date for the purpose of Rights Issue of Equity Shares. The transactions in the equity shares of the Company should be done on ex-rights basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Megasoft Limited. (532408) RECORD DATE 13.07.2021 PURPOSE Issue of 2 (two) equity shares of Rs. 10/- each on rights basis for every 3 (Three) equity shares held. Ex-Right basis from Date & Sett. No. 12/07/2021 DR-071/2021-2022 Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 08.07.2021)	13-Jul-2021	2:3
30-Jan-2002	R	Two equity shares of Rs.10/- each at a premium of Rs.15/- per share on rights basis for every five existing equity share held.	26-Feb-2002	2:5
12-Apr-2024	BC	This is to inform you that the Board of Directors of the Company at its meeting held on April 12,2024 have considered and discussed upon offer from the foreign promoters of Extrovis AG, an associate	12-Apr-2024
28-Mar-2024	BC	Ramanagaram Enterprises Pvt Ltd	28-Mar-2024
26-Mar-2024	BC	Ramanagaram Enterprises Pvt Ltd	26-Mar-2024
22-Mar-2024	BC	Ramanagaram Enterprises Pvt Ltd (Sales Dated on 18/03/2024 to 22/03/2024)	18-Mar-2024
01-Feb-2024	BC	MEGASOFT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve We wish to inform you that pursuant to Regulation	09-Feb-2024

Record Date01 Jan'1900

Ex-Rights Date01 Jan'1900

Premium(Rs.)0

Ratio2:3

Record Date01 Jan'1900

Ex-Rights Date01 Jan'1900

Premium(Rs.)15

Ratio2:5

Book Closure

Record Date	Split Date	Purpose
12-Apr-2024	-	This is to inform you that the Board of Directors of the Company at its meeting held on April 12,2024 have considered and discussed upon offer from the foreign promoters of Extrovis AG, an associate
28-Mar-2024	-	Ramanagaram Enterprises Pvt Ltd
26-Mar-2024	-	Ramanagaram Enterprises Pvt Ltd
18-Mar-2024	-	Ramanagaram Enterprises Pvt Ltd (Sales Dated on 18/03/2024 to 22/03/2024)
09-Feb-2024	-	MEGASOFT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve We wish to inform you that pursuant to Regulation

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Megasoft Ltd ₹77.29(+1.03/1.35%)	77.29	+1.03	570.17	123.32	55.21	3.26
Astrazeneca Pharma India Ltd ₹5,415.40(+81.55/1.53%)	5,415.40	+81.55	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹122.60(+5.85/5.01%)	122.60	+5.85	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,409.40(+4.00/0.28%)	1,409.40	+4.00	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹25,864.85(+201.35/0.78%)	25,864.85	+201.35	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹680.85(-8.80/-1.28%)	680.85	-8.80	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	7.73	10.80	11.21	11.11	11.43	11.31
Total Income	7.73	10.80	11.21	11.11	11.43	11.31
Total Expenditure	2.40	2.48	2.59	2.96	3.37	6.02
PBIDT	5.34	8.32	8.62	8.15	8.06	5.29
Interest	4.21	4.14	4.17	4.27	3.50	2.40
PBDT	1.13	4.18	4.44	3.88	4.56	2.90
Depreciation	0.67	0.67	0.67	0.66	0.66	0.62
Tax	0.00	0.08	0.55	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	0.46	3.42	3.22	3.22	3.90	2.28
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.46	3.42	3.22	3.22	3.90	2.28

EPS (Unit Curr.)	0.06	0.46	0.44	0.44	0.53	0.31
EPS (Adj) (Unit Curr.)	0.06	0.46	0.44	0.44	0.53	0.31
Calculated EPS (Unit Curr.)	0.06	0.46	0.44	0.44	0.53	0.31
Calculated EPS (Adj) (Unit Curr.)	0.06	0.46	0.44	0.44	0.53	0.31
Calculated EPS (Ann.) (Unit Curr.)	0.25	1.86	1.75	1.75	2.12	1.23
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.25	1.86	1.75	1.75	2.12	1.23
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	73.77	73.77	73.77	73.77	73.77	73.77
Reserve & Surplus	101.58	101.12	97.70	94.48	91.26	87.36
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PBDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PATM(%)	0.00	0.00	0.00	0.00	0.00	0.00

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	7.74	10.80	11.24	11.11	11.43	11.31
Total Income	7.74	10.80	11.24	11.11	11.43	11.31
Total Expenditure	2.40	2.49	2.59	2.97	3.37	6.02
PBIDT	5.34	8.31	8.65	8.14	8.06	5.29
Interest	4.20	4.14	4.17	4.27	3.50	2.40
PBDT	1.13	4.17	4.48	3.87	4.56	2.90
Depreciation	0.67	0.67	0.67	0.66	0.66	0.62
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.08	0.55	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	0.46	3.41	3.25	3.22	3.90	2.28
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	-4.80	-3.27	3.46	2.51	2.06	2.28

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-4.80	-3.27	3.46	2.51	2.06	2.28

EPS (Unit Curr.)	-0.65	-0.44	0.44	0.44	0.28	0.31
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	73.77	73.77	73.77	73.77	73.77	73.77

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PBDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PATM(%)	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	73.77	73.77	44.27	44.27	44.27	44.27
Reserves Total	122.22	110.74	105.28	103.96	103.41	97.35
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	195.99	184.51	149.55	148.23	147.68	141.62
Secured Loans	145.80	25.00	1.12	8.48	12.11	16.06
Unsecured Loans	0.00	4.03	4.95	0.50	0.00	0.93
Total Debt	145.80	29.03	6.07	8.98	12.11	16.99
Total Liabilities	341.79	213.54	155.62	157.21	159.79	158.61
APPLICATION OF FUNDS :
Gross Block	186.39	196.55	160.22	154.66	121.27	28.29
Less : Accumulated Depreciation	7.20	11.58	22.70	19.98	16.53	15.55
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	179.19	184.97	137.52	134.68	104.74	12.74
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	30.81	57.61
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	136.02	6.52	33.96	33.96	33.96	56.17
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.00	0.00	0.00	0.00	0.00
Sundry Debtors	0.00	8.98	28.23	44.56	38.23	47.63
Cash and Bank	8.43	34.19	0.66	0.45	1.19	0.37
Loans and Advances	49.99	20.25	12.26	11.53	12.16	11.42
Total Current Assets	58.42	63.43	41.14	56.54	51.57	59.42
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	14.40	21.06	98.76	109.26	107.17	79.42
Provisions	1.06	0.73	6.75	8.60	7.46	4.21
Total Current Liabilities	15.46	21.79	105.52	117.86	114.63	83.63
Net Current Assets	42.96	41.63	-64.37	-61.32	-63.06	-24.21
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	4.22	2.22	0.58	0.92
Deferred Tax Liability	0.00	0.00	3.60	1.60	0.00	0.00
Net Deferred Tax	0.00	0.00	0.62	0.62	0.58	0.92
Total Assets	358.17	233.13	107.73	107.95	107.03	103.24
Contingent Liabilities	1.18	1.63	1.63	1.76	1.69	0.67

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	73.77	73.77	44.27	44.27	44.27	44.27
Reserves Total	119.56	110.73	97.38	96.10	93.05	91.01
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	193.33	184.50	141.65	140.37	137.32	135.28
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00
Secured Loans	145.80	25.00	29.50	39.65	40.82	43.06
Unsecured Loans	0.00	4.03	4.95	0.50	0.00	3.99
Total Debt	145.80	29.03	34.45	40.15	40.82	47.05
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	22.21	21.02	17.04	15.62	12.11	10.28
Total Liabilities	361.34	234.55	193.14	196.14	190.25	192.61
APPLICATION OF FUNDS :
Gross Block	186.39	215.68	400.36	394.59	346.41	272.77
Less: Accumulated Depreciation	7.20	11.58	152.39	151.84	138.68	131.68
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	179.19	204.10	247.97	242.75	207.73	141.09
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	30.81	57.61
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	132.81	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.00	0.00	0.00	0.00	0.00
Sundry Debtors	0.00	22.71	31.14	59.33	58.47	74.61
Cash and Bank	8.99	37.24	7.24	6.17	3.04	0.90
Loans and Advances	49.98	20.67	28.92	21.02	19.76	20.33
Total Current Assets	58.97	80.61	67.30	86.52	81.27	95.85
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	14.41	50.07	116.23	126.52	124.03	98.61
Provisions	1.06	1.52	7.95	8.60	7.46	5.62
Total Current Liabilities	15.46	51.59	124.18	135.13	131.49	104.23
Net Current Assets	43.51	29.02	-56.88	-48.60	-50.23	-8.39
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	4.22	2.22	0.57	0.92
Deferred Tax Liability	0.00	0.00	3.60	1.61	0.00	0.00
Net Deferred Tax	0.00	0.00	0.62	0.61	0.57	0.92
Other Assets	5.83	1.43	1.44	1.37	1.36	1.36
Total Assets
Contingent Liabilities	1.18	1.63	1.63	1.76	1.69	0.67

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	32.20	0.18	0.12	0.74	0.09
Net Cash from Operating Activities	12.87	22.97	10.87	7.12	47.98
Net Cash Used In Investing Activities	-146.53	-42.28	-0.71	-0.56	-38.55
Net Cash Used In Financing Activities	103.19	51.32	-10.09	-7.18	-8.78
Net Inc./Dec In Cash And Cash Equivalents	-30.47	32.02	0.07	-0.62	0.65
Cash And Cash Equivalents At End Of The Year	1.73	32.20	0.18	0.12	0.74

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

43.54%

FII Shareholding

0.05%

DII Shareholding

0.00%

Public Shareholding

56.41%

**Promoter pledged shareholding 43.54%

About Megasoft Ltd

Megasoft Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 570.17 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. 0.46 crores for the quarter ended December 2018. The company management includes , Sunil Kumar Kalidindi,Anish Mathew,Leona Ambuja,Kalyan Vijay Sivalenka,Suryanarayana Raju Nandyala,Krishna Yeachuri,Srivalli Susarla (Megasoft Ltd) among others.

Chairman

Registered office

85 Kutchery Road,Mylapore,Chennai,Tamil Nadu,600004

FAX :91-44-24617810

Background

Incorporation Year1999

Face Value₹10

Market Lot1

How to buy Megasoft shares on nse?

To buy Megasoft shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Megasoft share price today?

The Megasoft shares price on nse is Rs.77.29 today.

What is the market cap of Megasoft shares on BSE ?

The company has a market capitalization of Rs.570.17Cr

What is the PE & PB ratio of Megasoft shares ?

PE is 55.21 and PB is 3.26

What is the 52 Week High and Low of Megasoft shares?

Megasoft stock price high: Rs.107.22 Megasoft stock price low: Rs.28.55